Direct regulation of myelin protein zero expression by the Egr2 transactivator.
about
An EGR2/CITED1 transcription factor complex and the 14-3-3sigma tumor suppressor are involved in regulating ErbB2 expression in a transgenic-mouse model of human breast cancerReciprocal co-regulation of EGR2 and MECP2 is disrupted in Rett syndrome and autismMicroprocessor complex subunit DiGeorge syndrome critical region gene 8 (Dgcr8) is required for schwann cell myelination and myelin maintenanceActive gene repression by the Egr2.NAB complex during peripheral nerve myelinationAnalysis of peripheral nerve expression profiles identifies a novel myelin glycoprotein, MP11Calcineurin/NFAT signaling is required for neuregulin-regulated Schwann cell differentiationNeuropathy-Associated Egr2 Mutants Disrupt Cooperative Activation of Myelin Protein Zero by Egr2 and Sox10SOX10 regulates expression of the SH3-domain kinase binding protein 1 (Sh3kbp1) locus in Schwann cells via an alternative promoterM2 muscarinic receptor activation regulates Schwann cell differentiation and myelin organization.Congenital hypomyelinating neuropathy with lethal conduction failure in mice carrying the Egr2 I268N mutation.Gene expression profiling of lymphoblastoid cell lines from monozygotic twins discordant in severity of autism reveals differential regulation of neurologically relevant genes.Differential regulation of NAB corepressor genes in Schwann cells.Identification of neural crest and glial enhancers at the mouse Sox10 locus through transgenesis in zebrafish.A rare myelin protein zero (MPZ) variant alters enhancer activity in vitro and in vivo.MicroRNA-deficient Schwann cells display congenital hypomyelinationThe molecular machinery of myelin gene transcription in Schwann cells.The PMP22 gene and its related diseases.NAB2 represses transcription by interacting with the CHD4 subunit of the nucleosome remodeling and deacetylase (NuRD) complex.SWI/SNF enzymes promote SOX10- mediated activation of myelin gene expressionRegulation of the PMP22 gene through an intronic enhancer.Playing the field: Sox10 recruits different partners to drive central and peripheral myelinationDynamic regulation of Schwann cell enhancers after peripheral nerve injuryLocus-wide identification of Egr2/Krox20 regulatory targets in myelin genesERK1 and ERK2 regulate chondrocyte terminal differentiation during endochondral bone formationDistal enhancers upstream of the Charcot-Marie-Tooth type 1A disease gene PMP22Repeat-induced epigenetic changes in intron 1 of the frataxin gene and its consequences in Friedreich ataxiaGenome-wide analysis of EGR2/SOX10 binding in myelinating peripheral nerve.Stringent comparative sequence analysis reveals SOX10 as a putative inhibitor of glial cell differentiation.Role for Egr1 in the Transcriptional Program Associated with Neuronal Differentiation of PC12 Cells.Differential Sox10 genomic occupancy in myelinating glia.c-Jun is a negative regulator of myelination.Loss-of-function mutations in SOX10 cause Kallmann syndrome with deafnessMolecular mechanisms of inherited demyelinating neuropathies.Interactions of Sox10 and Egr2 in myelin gene regulationOptimal myelin elongation relies on YAP activation by axonal growth and inhibition by Crb3/Hippo pathway.Induction of myelin protein zero by early growth response 2 through upstream and intragenic elements.MicroRNA and transcriptional crosstalk in myelinating glia.Transcriptional control of neural crest specification into peripheral glia.In vivo detection of Egr2 binding to target genes during peripheral nerve myelination.Proteolipid protein modulates preservation of peripheral axons and premature death when myelin protein zero is lacking.
P2860
Q24297853-29888815-7E33-4A75-9480-DE6D417ABC3DQ24655487-7281E166-2F04-4F72-9242-C99E18D49923Q27313433-00F16DE4-36F0-4F2A-921E-EB3BE7CB6225Q28564369-DC4F9235-0C8C-4DE4-9FD9-C71F2C4045D4Q28565981-DCDBF365-3337-4EB5-B973-1EFF391FB7E4Q28588209-E3EAE0E1-83F2-478A-B1A2-2BD12D2E7B57Q28972409-6EBBF267-B34F-4982-9468-B17839865858Q30010215-735B983C-E871-48B3-A2F5-76ABB441034CQ30273753-5C40A83D-6931-4100-AA5A-B8F87B557B19Q30487517-76046C24-5D4E-4506-A224-BAC3CCF9FCBDQ33243918-C1730239-D819-4B86-BD2F-9929D76E59C5Q33311623-525014F8-558D-4886-825E-C5C17A3B6F74Q33367100-D4A9AC87-19BB-4CCD-8C18-A21C8A1E1FF5Q33778705-627C3EEA-9272-43E1-9958-A6631FB937D5Q34004508-40BFE55A-E39A-4FD1-BBD0-23FFDF8DDCF8Q34092185-7522F34D-011E-4BCF-ADBD-F2BD1C4C0E5AQ34316615-E9559895-B23E-49AA-80B1-1C8412D9DC63Q34507079-B3DD9930-2809-4B8C-95F2-F0C54E9B67C4Q34852520-008E0AC5-4789-41FE-965A-8A27E49A4A21Q35001004-9BB615AC-B2BB-41B5-AE93-9AD06B52B8F9Q35034376-1CFCA91D-8604-43E1-AB6E-0AB046A0BF47Q35172633-DB96ACD6-5703-47EF-8876-5F18AE9B947EQ35677229-AD620CB5-BFED-46BD-ABA6-D6B1550BEB8FQ35805977-6A0607A4-9BA7-4FAD-9BA8-003F01FA052CQ35817491-310E4971-B705-45F4-BDEF-F2AF0FA4D017Q35865338-77C4F6F5-6AF0-43F7-A56D-8DE2B7516745Q36144788-4FA154CF-24BD-4A35-9804-CB82D6C5F299Q36184503-78355D0C-630D-4987-B883-34045FEE6FFFQ36246379-BE726842-D706-45EF-8BD0-E6EE72235766Q36279083-DEF6D867-2A49-40EB-8ED7-224696DF127AQ36660683-995822D6-980F-4045-AFCD-87AB11B352A3Q36817329-50BA971D-BA3E-43B1-9071-DC48EFBB6065Q36942808-0A482FDF-0122-46A1-84F7-82DB8B3AADE6Q37020396-9E08FC06-765A-4FCC-B5FC-0B58D8CC9D26Q37127817-C68CEE41-CDCD-4FF6-9F52-50975C067CE3Q37339015-345FC811-00A3-4731-A917-6A61BB2BE3F4Q38224732-206F3C1B-C40F-4092-8B65-0EFA91D981D4Q38370706-168CAAE7-9556-4950-9329-E598C026BDEEQ39100875-732FC455-1CC8-467F-BA42-C51D160CFE5FQ40515513-0148978D-FA94-4A74-AB61-2F190232F038
P2860
Direct regulation of myelin protein zero expression by the Egr2 transactivator.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Direct regulation of myelin protein zero expression by the Egr2 transactivator.
@en
type
label
Direct regulation of myelin protein zero expression by the Egr2 transactivator.
@en
prefLabel
Direct regulation of myelin protein zero expression by the Egr2 transactivator.
@en
P2093
P2860
P356
P1476
Direct regulation of myelin protein zero expression by the Egr2 transactivator.
@en
P2093
Lawrence Wrabetz
Rebecca M Ward
Scott E LeBlanc
Sung-Wook Jang
P2860
P304
P356
10.1074/JBC.M512159200
P407
P50
P577
2005-12-22T00:00:00Z